Project Grant HT94252410947
Award Date
8/1/24
Completion Date
7/31/27
Dollars Obligated
$848K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Research Triangle Park, Durham, NC, USA
Similar Awards
The Denver Research Institute will receive $768,919 under a four-year Project Grant award from the Department of the Army Medical Command. The grant will fund research from September 2022 through September 2026 under the Military Medical Research and Development program (CFDA 12.420). The research aims to prevent suicide among survivors of military sexual violence by identifying critical risk periods and factors that attenuate or exacerbate suicide risk. The Military Medical Research and...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,326,715 to the Boston VA Research Institute, Inc. (BVARI) to develop and conduct a preliminary evaluation of a self-directed, internet-based Cognitive Processing Therapy (CPT) intervention. The funding period is from September 1, 2024 to August 31, 2028. The key products and services to be delivered under this grant include: Developing the web-based CPT...
This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
The federal Project Grant award, EXAMINING THE EFFICACY OF THE MAN THERAPY PLATFORM IN REDUCING PROBLEMATIC ANGER AMONG MILITARY SERVICE MEMBERS WITH AND WITHOUT A TBI HISTORY: AN RCT, is funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The $2,339,999.00 award was granted to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to conduct a randomized controlled trial (RCT)...
This $3,823,679 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development and evaluation of a web-based training program for brief cognitive behavioral therapy (BCBT) for suicide prevention. The prime awardee, The Ohio State University, is collaborating with subrecipients The University of Texas Health Science Center at San Antonio, the Medical University of South Carolina, and the University of Memphis...
This federal Project Grant award of $267,311 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The award was made to The Ohio State University, which will serve as the prime recipient, with a performance period from August 1, 2024 to July 31, 2027. The project aims to...
The Defense Health Agency awarded The Ohio State University a $8,375,496 cooperative agreement under the Military Medical Research and Development program (CFDA 12.420) from September 30, 2022 to September 29, 2026. This award will fund the Augmenting Suicide Prevention Interventions for Service Members project, which consists of five synergistic studies that aim to identify the strategies, delivery methods, providers, and circumstances most effective for preventing suicidality among military...
The U.S. Defense Health Agency awarded a $2,534,532 Project Grant to Rush University Medical Center to evaluate evidence-based options for initial PTSD treatment non-responders. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a comprehensive range of biomedical research initiatives aimed at improving health outcomes for military service members, veterans, and the broader public. The award has a performance period of September 1,...
This federal Project Grant award, valued at $3,141,404.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized controlled trial to evaluate the efficacy of combined cognitive processing therapy and stellate ganglion blocks for the treatment of post-traumatic stress disorder (PTSD). The award was granted to Rush University Medical Center, a prominent academic medical center in Chicago, Illinois, to conduct this...
The federal Project Grant award of $5,954,349.00, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a randomized controlled trial to optimize heart rate variability treatment for combat veterans and service members with persistent post-concussion symptoms. The primary awardee, Virginia Commonwealth University, will collaborate with sub-awardees Palo Alto Veterans Institute For Research and Richmond Institute For Veterans...